Sandra L. Kane‐Gill

13.0k total citations
256 papers, 6.4k citations indexed

About

Sandra L. Kane‐Gill is a scholar working on Geriatrics and Gerontology, Critical Care and Intensive Care Medicine and Nephrology. According to data from OpenAlex, Sandra L. Kane‐Gill has authored 256 papers receiving a total of 6.4k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Geriatrics and Gerontology, 49 papers in Critical Care and Intensive Care Medicine and 47 papers in Nephrology. Recurrent topics in Sandra L. Kane‐Gill's work include Pharmaceutical Practices and Patient Outcomes (68 papers), Patient Safety and Medication Errors (45 papers) and Acute Kidney Injury Research (42 papers). Sandra L. Kane‐Gill is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (68 papers), Patient Safety and Medication Errors (45 papers) and Acute Kidney Injury Research (42 papers). Sandra L. Kane‐Gill collaborates with scholars based in United States, Canada and United Kingdom. Sandra L. Kane‐Gill's co-authors include Pamela L. Smithburger, Joseph F. Dasta, Amy L. Seybert, John A. Kellum, Robert J. Weber, Mitchell S. Buckley, Steven M. Handler, Jeffrey M. Rothschild, Amy J. Durtschi and Dev S. Pathak and has published in prestigious journals such as Blood, CHEST Journal and The American Journal of Medicine.

In The Last Decade

Sandra L. Kane‐Gill

245 papers receiving 6.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sandra L. Kane‐Gill United States	44	1.5k	1.3k	1.2k	1.1k	976	256	6.4k
Josh F. Peterson United States	42	2.0k 1.3×	2.1k 1.6×	1.2k 1.0×	975 0.9×	578 0.6×	121	9.3k
Joseph F. Dasta United States	39	483 0.3×	1.8k 1.4×	479 0.4×	754 0.7×	1.5k 1.5×	161	6.0k
Brian L. Erstad United States	37	899 0.6×	1.2k 0.9×	985 0.8×	127 0.1×	863 0.9×	279	5.1k
David W. Bates United States	38	2.0k 1.3×	867 0.7×	1.8k 1.6×	2.4k 2.2×	1.4k 1.4×	98	10.3k
Elisabeth Burdick United States	27	1.9k 1.3×	642 0.5×	2.5k 2.1×	2.1k 1.9×	1.3k 1.3×	51	9.2k
Philipp Metnitz Austria	34	322 0.2×	1.4k 1.1×	558 0.5×	1.5k 1.4×	2.0k 2.0×	103	7.4k
Brian H. Cuthbertson United Kingdom	37	247 0.2×	2.0k 1.6×	524 0.4×	343 0.3×	1.5k 1.5×	154	7.9k
Peter Dodek Canada	56	366 0.2×	3.1k 2.4×	545 0.5×	538 0.5×	1.2k 1.2×	233	11.6k
Ronald I. Shorr United States	49	1.4k 0.9×	329 0.3×	259 0.2×	345 0.3×	803 0.8×	145	7.1k
Hannah Wunsch United States	54	696 0.5×	2.6k 2.1×	463 0.4×	188 0.2×	1.8k 1.8×	250	10.0k

Countries citing papers authored by Sandra L. Kane‐Gill

Since Specialization

Citations

This map shows the geographic impact of Sandra L. Kane‐Gill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra L. Kane‐Gill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra L. Kane‐Gill more than expected).

Fields of papers citing papers by Sandra L. Kane‐Gill

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra L. Kane‐Gill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra L. Kane‐Gill. The network helps show where Sandra L. Kane‐Gill may publish in the future.

Co-authorship network of co-authors of Sandra L. Kane‐Gill

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra L. Kane‐Gill. A scholar is included among the top collaborators of Sandra L. Kane‐Gill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra L. Kane‐Gill. Sandra L. Kane‐Gill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sikora, Andrea, Brian Murray, Susan Smith, et al.. (2025). Consensus recommendations for the integration of critical care pharmacists on intensive care unit teams: Endorsed by the American Association of Critical‐Care Nurses, American College of Clinical Pharmacy, American Society of Health‐System Pharmacists, Institute for Safe Medication Practices, and Society of Critical Care Medicine. JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 8(9). 914–930. 1 indexed citations

Kane‐Gill, Sandra L.. (2025). Kidney Damage Biomarkers: A Missing Piece of the Diagnostic and Management Puzzle for Acute Drug‐Related Kidney Diseases. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 45(11). 714–720.

Wong, Adrian, et al.. (2025). Forecasting the impact of artificial intelligence on clinical pharmacy practice. JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 8(4). 302–310. 2 indexed citations

Guo, Jingchuan, Sandra L. Kane‐Gill, Nico Gabriel, et al.. (2025). Use of Potentially Nephrotoxic Drugs in Type 2 Diabetes Patients on SGLT2i: A Trajectories Analysis. Pharmacoepidemiology and Drug Safety. 34(2). e70098–e70098.

Wallace, J., Erica Anderson, Wasim S. El Nekidy, et al.. (2025). Adopting Race‐Free Estimated Glomerular Filtration Rate for Unifying Medication‐Related Decision‐Making: An Opinion of the Nephrology Practice and Research Network of the American College of Clinical Pharmacy. JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 9(2).

Karimzadeh, Iman, Mojtaba Shafiekhani, Reza Heidari, et al.. (2024). Protective effects of silymarin on preventing vancomycin nephrotoxicity in infectious patients: a randomized, double-blinded, placebo-controlled, pilot clinical trial. Naunyn-Schmiedeberg s Archives of Pharmacology. 398(3). 2945–2960. 1 indexed citations

Huang, David T., Sandra L. Kane‐Gill, Ryan Rivosecchi, et al.. (2024). Metformin for sepsis-associated AKI: a protocol for the Randomized Clinical Trial of the Safety and FeasibiLity of Metformin as a Treatment for sepsis-associated AKI (LiMiT AKI). BMJ Open. 14(4). e081120–e081120. 5 indexed citations

Kane‐Gill, Sandra L., et al.. (2024). Part 2: Drug Interactions Involving Cannabis Products in Persons Aged 18 and Over: A Summary of Published Case Reports and Analysis of the FDA Adverse Event Reporting System. Pharmacology Research & Perspectives. 13(1). e70047–e70047. 1 indexed citations

Li, Xiaotong, et al.. (2023). An evaluation of adverse drug reactions and outcomes attributed to kratom in the US Food and Drug Administration Adverse Event Reporting System from January 2004 through September 2021. Clinical and Translational Science. 16(6). 1002–1011. 9 indexed citations

10.

Callahan, Tiffany J., Mary F. Paine, Sandra L. Kane‐Gill, et al.. (2023). Developing a Knowledge Graph for Pharmacokinetic Natural Product-Drug Interactions. Journal of Biomedical Informatics. 140. 104341–104341. 8 indexed citations

11.

Barreto, Jason N., James C. Coons, Kellie J. Goodlet, et al.. (2023). Best practices for supporting and improving pharmacy resident research and quality improvement projects. JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 7(1). 75–84. 2 indexed citations

12.

Gray, Matthew P., Erin F. Barreto, John A. Kellum, et al.. (2022). Consensus Obtained for the Nephrotoxic Potential of 167 Drugs in Adult Critically Ill Patients Using a Modified Delphi Method. Drug Safety. 45(4). 389–398. 22 indexed citations

13.

Kim, Hyunwoo, et al.. (2021). Assessing Adverse Drug Reactions Reported for New Respiratory Medications in the FDA Adverse Event Reporting System Database. Respiratory Care. 66(11). 1739–1745. 2 indexed citations

14.

Wong, Adrian, et al.. (2019). Evaluation of Potential Drug–Drug Interactions in Adults in the Intensive Care Unit: A Systematic Review and Meta-Analysis. Drug Safety. 42(9). 1035–1044. 39 indexed citations

15.

Fuhrman, Dana Y., Sandra L. Kane‐Gill, Stuart L. Goldstein, Priyanka Priyanka, & John A. Kellum. (2018). Acute kidney injury epidemiology, risk factors, and outcomes in critically ill patients 16–25 years of age treated in an adult intensive care unit. Annals of Intensive Care. 8(1). 26–26. 43 indexed citations

16.

Smithburger, Pamela L., Randall B. Smith, Sandra L. Kane‐Gill, & Philip E. Empey. (2014). Patient Predictors of Dexmedetomidine Effectiveness for Sedation in Intensive Care Units. American Journal of Critical Care. 23(2). 160–165. 20 indexed citations

17.

Kane‐Gill, Sandra L. & Pamela L. Smithburger. (2011). Transitioning Knowledge Gained From Simulation to Pharmacy Practice. American Journal of Pharmaceutical Education. 75(10). 210–210. 50 indexed citations

18.

Yan, Feng, Bruce Green, Stephen B. Duffull, et al.. (2006). Development of a dosage strategy in patients receiving enoxaparin by continuous intravenous infusion using modelling and simulation. British Journal of Clinical Pharmacology. 62(2). 165–176. 13 indexed citations

19.

Kane‐Gill, Sandra L., Feng Yan, Mary Beth Bobek, et al.. (2005). Administration of enoxaparin by continuous infusion in a naturalistic setting: analysis of renal function and safety1. Journal of Clinical Pharmacy and Therapeutics. 30(3). 207–213. 15 indexed citations

20.

Erstad, Brian L., et al.. (2001). Medication administration errors in adult patients in the ICU. Intensive Care Medicine. 27(10). 1592–1598. 139 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact